PAI pharma acquires nexus pharmaceuticals expanding sterile injectable portfolio
PAI pharma announced the acquisition of nexus pharmaceuticals, adding an established commercial portfolio of over 20 hospital injectable products. The deal builds on PAI's investment in domestic sterile manufacturing and expands its hospital-focused pharmaceutical portfolio.
Primary source
Company press release (PR Newswire), November 12, 2026
PAI Pharma Acquires Nexus Pharmaceuticals, Expanding Portfolio of Sterile Injectable Products
Read the source: PAI Pharma Acquires Nexus Pharmaceuticals, Expanding Portfolio of Sterile Injectable Products prnewswire.com
Machine-summarized from the source above; not independently reported. How we use automation